Astrana Health (ASTH) Competitors $27.75 -0.33 (-1.18%) As of 01:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASTH vs. STNE, APLD, AMTM, WPP, FTDR, QMMM, DLO, HNGE, WSC, and HRIShould you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include StoneCo (STNE), Applied Digital (APLD), Amentum (AMTM), WPP (WPP), Frontdoor (FTDR), QMMM (QMMM), DLocal (DLO), Hinge Health (HNGE), WillScot (WSC), and Herc (HRI). These companies are all part of the "business services" industry. Astrana Health vs. Its Competitors StoneCo Applied Digital Amentum WPP Frontdoor QMMM DLocal Hinge Health WillScot Herc StoneCo (NASDAQ:STNE) and Astrana Health (NASDAQ:ASTH) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk. Do insiders and institutionals have more ownership in STNE or ASTH? 73.2% of StoneCo shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 11.3% of StoneCo shares are owned by company insiders. Comparatively, 20.0% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher valuation & earnings, STNE or ASTH? Astrana Health has lower revenue, but higher earnings than StoneCo. StoneCo is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStoneCo$13.76B0.39-$280.92M-$0.70-26.78Astrana Health$2.03B0.76$43.15M$0.5154.41 Which has more risk & volatility, STNE or ASTH? StoneCo has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Do analysts recommend STNE or ASTH? StoneCo presently has a consensus target price of $16.56, indicating a potential downside of 11.64%. Astrana Health has a consensus target price of $53.29, indicating a potential upside of 92.02%. Given Astrana Health's higher probable upside, analysts plainly believe Astrana Health is more favorable than StoneCo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score StoneCo 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.92Astrana Health 1 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is STNE or ASTH more profitable? Astrana Health has a net margin of 1.04% compared to StoneCo's net margin of -8.37%. StoneCo's return on equity of 18.71% beat Astrana Health's return on equity.Company Net Margins Return on Equity Return on Assets StoneCo-8.37% 18.71% 4.36% Astrana Health 1.04%3.43%1.87% Does the media favor STNE or ASTH? In the previous week, StoneCo had 6 more articles in the media than Astrana Health. MarketBeat recorded 8 mentions for StoneCo and 2 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.87 beat StoneCo's score of 1.14 indicating that Astrana Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment StoneCo 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryStoneCo beats Astrana Health on 9 of the 17 factors compared between the two stocks. Get Astrana Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASTH vs. The Competition Export to ExcelMetricAstrana HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.56B$5.47B$5.65B$10.30BDividend YieldN/A1.28%5.68%4.61%P/E Ratio54.4127.8075.7126.17Price / Sales0.76192.42514.12169.29Price / Cash18.6227.7637.5661.52Price / Book1.904.6612.926.31Net Income$43.15M$197.51M$3.29B$270.94M7 Day Performance-6.85%-0.15%-0.14%0.11%1 Month Performance-7.28%0.79%3.97%6.67%1 Year Performance-50.20%19.37%68.37%28.91% Astrana Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASTHAstrana Health4.3364 of 5 stars$27.75-1.2%$53.29+92.0%-49.5%$1.56B$2.03B54.411,900STNEStoneCo3.7234 of 5 stars$19.19-1.1%$16.56-13.7%+67.4%$5.55B$2.46B-27.4116,793Positive NewsAPLDApplied Digital2.0554 of 5 stars$24.45+19.4%$15.64-36.0%+231.2%$5.52B$144.19M-22.43121Options VolumeGap DownAMTMAmentum3.7932 of 5 stars$22.84+2.2%$27.40+20.0%N/A$5.44B$8.39B58.5653,000Analyst UpgradeGap UpWPPWPP1.6606 of 5 stars$24.35+1.3%N/A-53.3%$5.19B$18.84B4.08108,044FTDRFrontdoor3.469 of 5 stars$68.04+1.7%$59.75-12.2%+37.9%$4.87B$1.84B20.072,120Positive NewsQMMMQMMMN/A$105.90+27.8%N/A+1,447.2%$4.74B$2.70M0.00N/ADLODLocal3.0514 of 5 stars$15.22+1.5%$14.00-8.0%+83.0%$4.68B$745.97M31.711,095Analyst DowngradeGap DownHNGEHinge HealthN/A$57.75+1.5%$56.47-2.2%N/A$4.46BN/A0.001,514News CoverageAnalyst ForecastWSCWillScot4.6844 of 5 stars$22.20-1.6%$36.00+62.2%-47.7%$4.11B$2.40B37.004,500Trending NewsAnalyst ForecastAnalyst RevisionHRIHerc3.6817 of 5 stars$124.37+4.4%$144.60+16.3%-22.2%$3.96B$3.57B144.617,600Positive News Related Companies and Tools Related Companies StoneCo Competitors Applied Digital Competitors Amentum Competitors WPP Competitors Frontdoor Competitors QMMM Competitors DLocal Competitors Hinge Health Competitors WillScot Competitors Herc Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASTH) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
